Inactivation of voltage-gated calcium channels is crucial for the spatiotemporal coordination of calcium signals and prevention of toxic calcium buildup. Only one member of the highly conserved family of calcium channel ␤-subunits-CaV␤-inhibits inactivation. This unique property has been attributed to short variable regions of the protein; however, here we report that this inhibition actually is conferred by a conserved guanylate kinase (GK) domain and, moreover, that this domain alone recapitulates CaV␤-mediated modulation of channel activation. We expressed and refolded the GK domain of CaV␤2a, the unique variant that inhibits inactivation, and of CaV␤1b, an isoform that facilitates it. The refolded domains of both CaV␤ variants were found to inhibit inactivation of CaV2.3 channels expressed in Xenopus laevis oocytes. These findings suggest that the GK domain endows calcium channels with a brake restraining voltage-dependent inactivation, and thus facilitation of inactivation by full-length CaV␤ requires additional structural determinants to antagonize the GK effect. We found that CaV␤ can switch the inactivation phenotype conferred to CaV2.3 from slow to fast after posttranslational modifications during channel biogenesis. Our findings provide a framework within which to understand the modulation of inactivation and a new functional map of CaV␤ in which the GK domain regulates channel gating and the other conserved domain (Src homology 3) may couple calcium channels to other signaling pathways.
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auxiliary subunit ͉ modular structure ͉ regulation C alcium signals mediate various cellular processes, including neurotransmission, excitation-contraction coupling, hormone secretion, and gene expression (1) . Voltage-gated calcium channels (VGCCs) are activated and inactivated on membrane depolarization, allowing transient increases in cytosolic Ca 2ϩ concentration. Voltage-dependent activation and inactivation of VGCCs depend strongly on the association of the ancillary ␤-subunit (Ca V ␤) to a highly conserved sequence within the intracellular loop joining the first and second repeats (loop I-II) of the pore-forming subunit (Ca V ␣ 1 ), known as the ␣-interaction domain (AID) (2) . Ca V ␤ is encoded by four nonallelic genes (␤ 1-4 ), each with multiple splice variants. Except for a few short splicing forms (3) , all of these genes share a common structural arrangement, consisting of two highly conserved regions separated and flanked by shorter variable sequences (Fig. 1A) . Crystallographic studies have revealed that whereas the first region encompasses a Src homology 3 (SH3) domain, the second region encompasses a guanylate kinase (GK) domain. The AID sequence forms an ␣-helix that fits into a hydrophobic cleft of the GK module that lies on the opposite side of the SH3 domain (Fig.  1B) (4) (5) (6) . This suggests that the isolated GK module may preserve at least some of the modulatory capabilities of the full Ca V ␤.
Despite several attempts to use different Ca V ␤ constructs and experimental approaches (7) (8) (9) (10) (11) , the functional competence of isolated GK and its ability to mimic Ca V ␤ function remain incompletely understood. A contributing factor may be the reduced stability of some GK-containing constructs (11) . To overcome this difficulty, we expressed and refolded the GK domain of two Ca V ␤ isoforms, Ca V ␤ 1b and Ca V ␤ 2a . These isoforms share modulatory effects on voltage-dependent activation and exhibit opposite actions on voltage-dependent inactivation. We studied the effect of the refolded GK modules on Xenopus oocytes expressing two types of ␣ 1 pore-forming subunits (Ca V 1.2 and Ca V 2.3) and compared it with the action of the recombinant full length and also the core of the Ca V ␤ protein containing both SH3 and GK domains. Whereas Ca V ␤ 2a is unique in its ability to inhibit voltage-dependent inactivation, the other Ca V ␤ isoforms facilitate this inactivation (12) (13) (14) (15) (16) (17) . Ca V ␤ 2a decelerates inactivation, increases the fraction of noninactivating current, and shifts the steady-state inactivation curve toward more positive potentials. These distinguishing modulatory properties of Ca V ␤ 2a have been broadly attributed to palmitoylation of the two contiguous cysteine residues at positions 3 and 4 in the N terminus region (15, (18) (19) (20) . Here, however, we report that instead, the GK modules derived from both Ca V ␤ 2a and Ca V ␤ 1b inhibit inactivation of Ca V 2.3 channels. This finding indicates that the structural determinants of inhibition of inactivation by Ca V ␤ 2a are encoded not in variable regions but rather within the GK domain. GK appears to endow calcium channels with a brake to impair voltage-dependent inactivation; therefore, masking the inhibitory effect of GK facilitates inactivation. We show that Ca V ␤ acquires this capability when co-expressed with Ca V ␣ 1 but not when added later during channel biogenesis. Moreover, Ca V ␤ 2a -GK increases peak currents and shifts the activation curve toward more negative potentials of Ca V 1.2 channels. Thus, GK emerges as a functional unit that recapitulates the hallmarks of Ca V ␤ modulation. appearing in the void volume of the size-exclusion chromatography column. At 0.1 mg/ml, Ca V ␤ 2a -GK eluted from the size-exclusion chromatography in a predominant peak, whereas Ca V ␤ 1b -GK exhibited a shoulder at this position and a main peak eluting near the albumin peak (Fig. 1C) . Both GK constructs migrated with an apparent molecular mass larger than that predicted by their amino acid sequences. This may reflect either an aberrant migration or formation of higher oligomeric states. To determine whether the refolded GK domains form multimers, we conducted a sucrose gradient analysis [supporting information (SI) Figs. S1-S3]. The Ca V ␤ 2a -GK distribution overlapped with a protein standard of 66 kDa, whereas Ca V ␤ 1b -GK appeared over a wider range, reaching a second standard of 29 kDa. Thus, our data are consistent with Ca V ␤ 2a -GK being essentially a dimer and Ca V ␤ 1b -GK being a mixture of dimers and monomers.
To assess the binding ability of Ca V ␤ 2a -GK to loop I-II, we fused the former to YFP (YFP-Ca V ␤ 2a -GK) and the latter to GST (GST-loop I-II). Ca V ␤ 2a -GK was seen to bind specifically to loop I-II; no association between GST and YFP-Ca V ␤ 2a -GK or between YFP and GST-loop I-II was detected (Fig. 1D ).
Cav␤2a-GK Increases Peak Current Amplitude and Shifts the Current-
Voltage Relationship of Ca v1.2 Channels. To investigate the modulation of voltage-dependent activation by Ca V ␤ 2a -GK, we used the Ca V 1.2␣ 1 subunit, because it exhibits little inactivation, and the coupling between voltage sensor and channel opening is extremely sensitive to the presence of Ca V ␤. This Ca V ␣ 1 isoform also is more suitable for monitoring channel expression through gating current measurements (21) . Injection of recombinant full-length Ca V ␤ 2a into oocytes expressing Ca V 1.2 channels results in an increase in the ionic current to charge movement ratio (I/Q) and a leftward shift in the current-voltage relationship (22) . Ca V ␤ 2a -SH3-GK proved to be equally robust in modulating the activation of Ca V 1.2 channels (Fig. 2A, Fig. S4 , and Table S1 ). Here, as in a previous report (22) , we measured charge movement by integrating outward transient currents at the onset of depolarizing pulses to the ionic current reversal potential. Injection of Ca V ␤ 2a -SH3-GK into Ca V 1.2-expressing oocytes increased the I/Q from 0.3 Ϯ 0.06 nA/pC (n ϭ 15) to 4.6 Ϯ 0.7 nA/pC (n ϭ 17), comparable to the values obtained after injection of Ca V ␤ 2a (4.5 Ϯ 0.9 nA/pC; n ϭ 18). The effect of Ca V ␤ 2a -GK was seen more clearly at reduced channel expression levels, where gating currents were barely visible and thus I/Q plots were not readily measurable. Nevertheless, the normalized current-voltage relationship was shifted to more-negative potentials and to similar extents with Ca V ␤ 2a (as protein or cRNA), Ca V ␤ 2a -SH3-GK, and Ca V ␤ 2a -GK (Fig. 2B) .
We attribute the limited activity of refolded Ca V ␤ 2a -GK to the low concentration of this protein, calculated as 0.3 M for a 525-nl oocyte. In addition, at high expression levels, a large amount of Ca V 1.2 subunit remained in the cytoplasm and may have acted as a sink. Another contributing factor could be the protein's decreased stability (see below). To overcome this potential problem, and inspired by a previous experiment demonstrating that Ca V ␤ 2a recapitulates channel modulation when attached to the C-termini of Ca V ␣ 1 (23), we covalently linked Ca V ␤-GK to Ca V 1.2 (Ca V 1.2-Ca V ␤ 2a -GK) and compared this with Ca V 1.2 linked to Ca V ␤ 2a (Ca V 1.2-Ca V ␤ 2a ). Table S1 for details).
conserved tryptophan within the AID (W470S) shown to prevent binding to Ca V ␤ (22), indicating that the changes in gating properties occurred through specific association of the fused GK moiety to the AID site and not from changes in channel activity generated by the GK linkage.
Cav␤2a-GK Inhibits Inactivation of Cav2.3 WT Channels. Next, we investigated the ability of Ca V ␤ 2a -GK to regulate inactivation kinetics, using the fast-inactivating Ca V 2.3 channels (Fig. 4) . Injection of refolded Ca V ␤ 2a -GK into Ca V 2.3-expressing oocytes resulted in a sixfold increase in the decay time to half-peak current amplitude (t 1 ⁄2; Fig. 4 A and B) ; however, Ca V ␤ 2a -GK co-injected as cRNA failed to modulate the Ca V 2.3-mediated currents. A greater increase in t 1 ⁄2 was observed after injection of full-length Ca V ␤ 2a , either as protein or co-injected as cRNA, and Ca V ␤ 2a -SH3-GK. Consistent with our earlier findings, Ca V ␤ 2a -SH3 decreased ionic currents without changing the time course (24) . The effect of refolded Ca V ␤ 2a -GK vanished 5 h after injection, indicating some degree of protein instability (Fig. 4C) ; this finding also may explain the lack of effect of Ca V ␤ 2a -GK cRNA. Both Ca V ␤ 2a -GK and Ca V ␤ 2a -SH3-GK shifted the steadystate inactivation curve of Ca V 2.3-mediated currents to more positive potentials. A residual current at the end of the pulse also emerged, but it was only a fraction of that seen with full-length Ca V ␤ 2a (Fig. 5) . Half-inactivation voltages (V 1 ⁄2), derived from the fit to a Boltzmann distribution plus the residual component, were similar with Ca V ␤ 2a -GK, Ca V ␤ 2a -SH3-GK, and full-length Ca V ␤ 2a but were significantly more positive than those with Ca V 2.3 alone (Fig. 5B and Table S2 ). Overall, Ca V ␤ 2a derivatives appear to be less effective than full-length Ca V ␤ 2a in inhibiting inactivation and may reflect a contribution of unoccupied Ca V 2.3 subunits. Nevertheless, inactivation of Ca V 2.3 channels bearing the W386S mutation that disrupt binding to Ca V ␤ (25) were not modulated by Ca V ␤ 2a or Ca V ␤ 2a -GK (Fig. S5) , indicating that the action of Ca V ␤ 2a -GK is AID-dependent and does not involve nonspecific binding. As in previous work (25), we also found that this substitution results in Ca V 2.3 channels that inactivate more slowly than wild-type channels. Taken together, these findings indicate that the N terminus of Ca V ␤ 2a is not mandatory for inhibiting inactivation and predict (owing to the highly conserved nature of the GK domain) that inhibition of inactivation is a property shared by all GKs in the various Ca V ␤ isoforms.
Cav␤1b-GK Resembles Cav␤2a in Inhibiting Inactivation of Cav2.3 WT Channels. We studied the effect of a GK module derived from Ca V ␤ 1b , an isoform that accelerates inactivation and shifts the steady-state inactivation curve to more negative potentials when co-expressed as cRNA (12) . Injection of refolded Ca V ␤ 1b -GK into oocytes expressing Ca V 2.3 channels yielded currents that inactivated slowly (t 1 ⁄2 ϭ 4.2 Ϯ 0.9 s, n ϭ 16; Fig. 6A ). Ca V ␤ 1b -GK also shifted the steady-state inactivation curves toward more depolarizing potentials and, like Ca V ␤ 2a -GK, induced a residual current (Fig. 6 B and C) . Based on these findings, we conclude that the GK module encompasses the minimal structural re- 
alone (t test; P Ͻ .01). (C) Time course of inhibition of inactivation by Ca V␤2a-GK.
Each bar corresponds to the average t 1 ⁄2 measured at different time intervals after protein injection. The first bar includes recordings from 12-50 min (n ϭ 4), and the second bar includes recordings from 51-100 min (n ϭ 6) and every 100 min thereafter (n ϭ 7, 2, and 4, respectively). The dashed line corresponds to t 1 ⁄2 for CaV2.3 alone.
quirements to inhibit voltage-dependent inactivation. A question that naturally arises is what determines the facilitation of inactivation by full-length Ca V ␤ proteins.

Full-Length CaV␤ Proteins Switch CaV2.3-Inactivation Phenotype De-
pending on the Time of Injection. Our finding that the GK module inhibits inactivation implies that full-length proteins that facilitate inactivation must be able to counteract the GK effect. This property has been documented for Ca V 2.3 channels coexpressed with cRNA encoding full-length Ca V ␤ 1b or a palmitoylation-deficient mutant of Ca V ␤ 2a bearing two cysteine-toserine substitutions at positions 3 and 4 (Ca V ␤ 2a C3,4S) (12, 18).
Here we report that injection of these Ca V ␤ constructs as proteins into oocytes already expressing Ca V 2.3 channels (late injection) slowed the time to inactivation compared with Ca V 2.3 alone (Fig. 7 A and B) . Furthermore, Ca V ␤ C3,4S shifted the steady-state inactivation curve toward more positive potentials ( Fig. 7 C and D and Table S2 ). Assuming that these full-length proteins were folded correctly, we conjectured that posttranslational modifications requiring longer times than allowed by the experiment were needed to confer their native phenotype.
Consequently, we co-injected these proteins together with the cRNA-encoding Ca V 2.3 subunit (co-injection) and indeed found that inactivation was accelerated ( Fig. 7 A and B) and the steady-state inactivation curve shifted toward more negative potentials ( Fig. 7 C and D and Table S2 ). These findings indicate that the recombinant proteins are properly folded, and that after posttranslational modifications during biogenesis of the channel complex, Ca V ␤ can switch the phenotype conferred to Ca V 2.3 from slow-inactivating to fast-inactivating.
Discussion
We have demonstrated that the GK module of the VGCC ␤ subunit recapitulates key modulatory properties of the full-length protein, and thus Ca V ␤-GK emerges as a functional competent domain. This implies that Ca V ␣ 1 -GK interaction suffices for channel gating regulation. Moreover, we have shown that regulation by GK is abolished by a mutation of the AID sequence, consistent with the idea that the AID-GK binding surface is critical for channel modulation (26) . Although our size-exclusion chromatography and sucrose gradient analysis revealed that purified GK domains formed dimers in solution, the finding that Ca V ␤ 2a -GK covalently linked to a Ca V 1.2 pore-forming subunit fully recapitulated the activation properties of the channel (Fig. 3) proves that the functional unit is a single GK molecule. Our experiments also demonstrate that Ca V ␤-GK can sustain the inhibition of voltagedependent inactivation of Ca V 2.3 channels. The prevailing view is that this phenotype is conferred uniquely by Ca V ␤ 2a , because it is anchored to the membrane and constrains the movement of the inactivating particle encoded by loop I-II (15, 27) . Our findings show that instead, inhibition of inactivation is not a unique feature of Ca V ␤ 2a , but rather is an inherent property of the GK module that appears to act as a brake to impair voltage-dependent inactivation. A corollary of this conclusion is that facilitation of inactivation by full-length Ca V ␤ requires additional structural determinants to antagonize GK's brake-like effect. Full-length proteins, Ca V ␤ 1b and Ca V ␤ 2a C3,4S, were able to counteract the action of GK only when they were co-injected with the Ca V 2.3-encoding cRNA, as if these 3-mediated currents in the presence of the specified protein during a steady-state inactivation pulse protocol. This consisted of a 10-s conditioning period to voltages of increasing amplitude, from Ϫ120 mV to ϩ30 mV in 15-mV increments, followed by a 0.4-s test pulse to 0 mV. Pulses were delivered once every 50 s from a holding potential of Ϫ90 mV. (B) Average steady-state inactivation curves from oocytes expressing Ca V2.3 alone (n ϭ 22) or after injection of full-length Ca V␤2a (n ϭ 13), CaV␤2a-SH3-GK (n ϭ 23), or CaV␤2a-GK (n ϭ 15). The continuous lines correspond to Boltzmann distributions plus a noninactivating current component that best described each set of data. For comparison, the Boltzmann distributions that best described the Ca V2.3 ϩ CaV␤2a cRNA data (dashed line) also are shown. The V 1 ⁄2 values for CaV2.3 ϩ CaV␤2a-GK and CaV2.3 ϩ Ca V␤2a-SH3-GK are significantly different than the V 1 ⁄2 measured in oocytes expressing Ca V2.3 alone (t test; P Ͻ .01) (see Table S2 for details). value for Ca V2.3 ϩ CaV␤1b-GK was significantly different from that measured in oocytes expressing Ca V2.3 alone (t test; P Ͻ .01) (see Table S2 for details).
determinants were acquired within a restricted time window during channel biogenesis. We envision that in cRNA or protein co-injection experiments, formation of the Ca V ␣ 1 -Ca V ␤ complex in early compartments, such as the endoplasmic reticulum, allows the necessary chemical or structural modifications to counteract GK's brakelike effect. Within this framework, palmitoylation may sequester Ca V ␤ 2a to other membranous compartments early in the course of biogenesis, hindering the formation of Ca V ␣ 1 -Ca V ␤ complexes in the compartment, which is permissible for these structural modifications. Alternatively, Ca V ␤ protein may gradually switch to a fast-inactivation-conferring phenotype over a period of several days independent of its location or association state. In any case, we conclude that fast inactivation relies on further posttranslational modifications of Ca V ␤, although the precise molecular mechanism remains to be identified.
In clear contrast to the protein injection experiments, we observed no modulation when Ca V ␤-SH3-GK or Ca V ␤-GK were co-injected as cRNA. Most likely, different parts of Ca V ␤ are important to either efficient translation or stability of the protein in the oocyte cytoplasm. Indeed, modulation of inactivation by Ca V ␤ 2a -GK, injected as protein, is rather transient compared with that of the full-length protein, indicating a reduced lifetime. This may explain why previous attempts by either co-expressing or co-injecting the protein more than 24 h before the recordings yielded seemingly contradictory results (7) (8) (9) (10) (11) . Although the time course of Ca V ␤ 2a -GK effect on Ca V 1.2 activation could not be determined, linking GK to Ca V 1.2 proved to be an effective strategy for stabilizing this module and increasing its potency. So far, we have been unable to express a concatamer of Ca V 2.3 with either the full-length Ca V ␤ or the GK domain.
As new protein partners are discovered, the functional role of Ca V ␤ is expanding rapidly (28, 29) . We recently found that the SH3 module of Ca V ␤ binds to the endocytotic protein dynamin (24) , and now we report that the GK module regulates calcium channel function. Together, these findings introduce a new perspective on Ca V ␤. Calcium entry through VGCCs on membrane depolarization ensures a transient change in intracellular calcium concentration that regulates diverse cellular functions. Integration of these different cellular processes must be tightly coordinated in living cells, and the domain architecture of Ca V ␤, with its two functionally independent modules, appears particularly well suited for orchestrating calcium signaling. We suggest that whereas GK regulates calcium entrance, the SH3 domain links channel activity to other cellular processes by binding to additional proteins.
Materials and Methods
Construction of cDNA and Protein Expression. cDNA encoding the GK domain (residues 201-422), the SH3-GK core (residues 24 -422) of rat ␤2a (Swiss-Prot Q8VGC3-2), and the GK domain (residues 209 -413) of the rat ␤1b (SwissProt P54283) were subcloned by polymerase chain reaction methods into a pRSET vector (Invitrogen). The predicted molecular masses of the Ca V␤1b-GK, Ca V␤2a-GK, and CaV␤2a-SH3-GK constructs, including the N-terminal His Tag, a transcript-stabilizing sequence, and the enterokinase cleavage recognition site, were 26.9 kDa, 28.6 kDa, and 48.2 kDa, respectively. Ca V␤2a-SH3 was prepared as described previously (24) . Full-length Ca V␤2a, the mutant bearing two substitutions at positions 3 and 4 (Ca V␤2a C3,4S) and Ca V␤2a-SH3-GK also were prepared as described previously (22) . CaV␤1b, Ca V␤1b-GK, and CaV␤2a-GK were expressed in bacteria and recovered from inclusion bodies as reported previously (30) . The GK domains were refolded by batch dilution (11-fold dilution) in refolding buffer (400 mM L-arginine, 2 mM NaEDTA, 0.5 mM glutathione oxidized, and 100 mM Tris base [pH 7.0]) and subsequently purified by size-exclusion chromatography onto a Superdex S-200 column (GE Healthcare) preequilibrated with nondenaturing buffer (20 mM Tris, 300 mM NaCl, and 1 mM EDTA [pH 8.0]). Proteins were concentrated up to 0.1 mg/ml by ultrafiltration (Amicon Ultra-4 10 kDa MWCO), rapidly frozen, and stored at Ϫ80°C until use. The identity of the purified proteins was confirmed by mass spectrometry analysis performed in the mass spectrometry laboratory of the Department of Pharmacology and Toxicology, Medizinische Hochschule Hannover. The protein was digested by trypsin, and the peptides were analyzed with an Ultraflex MALDI-TOF/TOF mass spectrometer (Bruker Daltonics).
The loop I-II of Ca V1.2 (Swiss-Prot P15381) fused to GST (GST-loop I-II) was prepared as described previously (30) . YFP was fused to Ca V␤2a-GK at its N terminus (YFP-Ca V␤2a-GK) and subcloned into the pcDNA 3.1 vector. The cDNA encoding Ca V1.2 was fused to the GK domain at the carboxyl-terminal end (Ca V1.2-CaV␤2a-GK) by overlapping extension polymerase chain reaction, which incorporated the sequence ''MGRDLYDDDDKD'' at residue 2164 of Ca V1.2. All constructs were verified by DNA sequencing.
Binding Assay. First, tsA201 cells were transfected with a YFP-CaV␤2a-GK or YFP-alone encoding vector and lysed after 24 -36 h. Precleared cell extracts were incubated for 1 h with glutathione beads coupled to either GST-loop I-II or GST alone. The beads were pelleted and washed, and bound proteins were eluted with SDS/PAGE loading buffer. Proteins were then resolved on SDS/PAGE and visualized by fluorescence scanning (Typhoon imager; GE Healthcare).
Oocyte Injection and Electrophysiologic Recordings. cRNA was synthesized and Xenopus laevis oocytes were prepared, injected, and maintained as reported previously (30) . The Ca V2.3 encoding cDNA was sequenced; compared with the Swiss-Prot entry Q15878, the following changes were noted: I649M, W837L, P838A, and insertion of a glycine residue at position 839. The Ca V1.2-subunit used in this study bears 60 aa deletion at the amino terminal (31) . Electrophysiologic recordings were performed with the cut-open oocyte technique 4 -6 days after cRNA injection and 1-7 hours after protein injection, as described previously (22 Table S2 for details).
